VATE
INNOVATE Corp. (NYSE)
Industrials — Engineering & Construction
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The company operates through the Infrastructure, Life Sciences, and Spectrum segments. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants; and manufacture of pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. This segment also offers solutions for digital engineering, modeling and detailing, construction, and heavy equipment installation and facility services, including maintenance, repair, and installation. Its Life Sciences segment develops products to treat early osteoarthritis of the knee; and aesthetic and medical technologies for the skin. The Spectrum segment operates over-the-air broadcasting stations across the United States. The company was formerly known as HC2 Holdings, Inc. and changed its name to INNOVATE Corp. in September 2021. The company was incorporated in 1994 and is headquartered in New York, New York.
Price History
Fundamentals
| Market Cap | $229.73M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-4.24 |
| Dividend Yield | 9.62% |
| Profit Margin | -3.96% |
| Revenue Growth | 33.00% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 48.0 |
| Beta | 2.34 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $21.30 |
| 52-Week Low | $3.75 |
| 50-Day Avg | $14.84 |
| 200-Day Avg | $7.72 |
| Avg Volume | 90.4K |
| Volume | 58.4K |
Performance Analysis
NEUTRALVATE presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:36 UTC
Back to Screener Export Report